甲状腺功能减退对慢性肾脏疾病患者动脉硬化的影响被引量：2

下载PDF

导出

摘要慢性肾脏疾病（ CKD）患者心血管疾病的发病率和死亡率普遍较高，而动脉硬化是导致CKD患者心血管疾病患病率增加的主要原因。研究发现，甲状腺激素（ TH）代谢异常在动脉硬化性心血管疾病的病理生理过程中扮演重要角色〔1，2〕。同时，流行病学调查显示CKD患者发生甲状腺功能减退的风险更大〔3〕。本文将对甲状腺功能减退对CKD患者动脉硬化的影响进行综述。

作者郭鑫杨俊

机构地区三峡大学心血管病研究所三峡大学第一临床医学院心内科

出处《中国老年学杂志》 CAS CSCD 北大核心 2014年第12期3493-3494,共2页 Chinese Journal of Gerontology

基金国家自然科学基金(No.81170133 81200088)

关键词慢性肾脏疾病甲状腺功能减退动脉硬化

分类号 R541.8 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献22

1Tatar E,Kircelli F,Asci G. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients[J].Clin J Am Soc Nephrol,2011,(09):2240-2246.
2Tatar E,Sezis Demirci M,Kircelli F. The association between thy-roid hormones and arterial stiffness in peritoneal dialysis patients[J].International Urology and Nephrology,2012,(02):601-606.
3Lo JC,Chertow GM,GoA S. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease[J].Kidney International,2005,(03):1047-1052.
4赵珉,郝丽,王笑薇,叶志恒.慢性肾衰竭患者甲状腺激素水平的变化及意义[J].安徽医学,2009,30(8):903-904. 被引量：12
5Song SH,Kwak IS,Lee DW. The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone[J].Nephrology Dialysis Transplantation,2009,(05):1534-1538.
6Peleg RK,Efrati S,Benbassat C. The effect of levothyroxine on ar-terial stiffness and lipid profile in patients with subclinical hypothyroidism[J].THYROID,2008,(08):825-830.
7Liu ML,Xu G,Huang ZY. Euthyroid sick syndrome and nutrition-al status are correlated with hyposelenemia in hemodialysis patients[J].International Journal of Artificial Organs,2011,(07):577-583.
8Liu ML,Huang ZY,Zhong XC. Th1 polarization and low-T3 syn-drome are correlated with hyperleptinemia in hemodialysis patients[J].Journal of Nephrology,2009,(04):515-522.
9吴旋,陈云欢,汪欣,潘金泉,陈宛珍,林莹.早期动脉硬化危险因素分析[J].国际检验医学杂志,2012,33(12):1492-1493. 被引量：10
10谢灵,温立新,李振江.动脉硬化与高血压、高血糖及高血脂的相关性[J].中国现代医药杂志,2009,11(9):99-99. 被引量：6

二级参考文献56

1Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis, 2001,38(Suppl 1 ):S80-S84.
2Thysen B, Gatz M, Freeman R, et al. Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysis. Nephron, 1983,33:49-52.
3De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab, 1999,84:151 -164.
4Zoccali C, Tripepi G, Cutrupi S, et al. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soe Nephrol , 2005,16:2 789-2 795.
5Giuseppe E, Vincenzo P, Sebastiano C. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl, 2007,22(2 ):538-544.
6Lo JC, Chertow GM, Go AS, et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int, 2005,67:1047-1052.
7Zoccali C, Mallamaci F, Tripepi G, et al. Low triiodothyronine and survival in end-stage renal disease.Kidney Int,2006,70: 523-528.
8Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis [J]. J Clin Endocrinol Metab ,2003.88 ( 6 ) :2438-2444.
9Mayer O Jr, Simon J, Filipovsky J, et al. Hypothyroidism in coronary heart disease and its relation to selected risk factors[J].Vasc Health Risk Manag,2006,2 ( 4 ) :499-506.
10Asvold BO, Vatten l J, Nilsen TI, et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The hunt study [ J ]. Eur J Endocrinol, 2007,156(2) :181-186.